David's research interests focus on the valuation of healthcare benefits. This includes describing health and valuing health states for the generation of quality-adjusted life years (QALYs) as well as the valuation and incorporation of broader outcomes (e.g. non-health outcomes or well-being) into the health technology assessment process.
David has expertise in the use of discrete choice experiments (DCEs) and other preference elicitation methodologies such as time trade-off (TTO) and contingent valuation (CV). He has an ongoing research interest in the use of patient preference information in healthcare decision-making (see Mott, 2018), which stemmed from his doctoral research.
At OHE, David has been working on a range of funded research and consulting projects. Recent and on-going examples include:
- A DCE study to elicit preferences from a sample of adults and a sample of adolescents for EQ-5D-Y health states, which may later be used to inform a UK value set for the measure.
- A patient preference study (using DCE and CV methodologies) within a wider project exploring the use of diagnostic tests to prevent antimicrobial resistance (AMR).
- A study exploring the differences between the EQ-5D-3L and EQ-5D-5L measures by comparing the responses of diabetes patients based in the UK.
- A literature review examining the existing evidence base with respect to the long-term health-related quality of life of cancer survivors.
David joined the Office of Health Economics in March 2017. David has a BSc in Economics and an MSc in Economics & Health Economics, both from the University of Sheffield, and recently completed his PhD at the Institute of Health & Society at Newcastle University.